Skip to content
OpenCapital
Get started

OS Therapies OSTX Debt-to-equity

Debt-to-equity at other companies

Immunome logo
ImmunomeIMNM
0×0.0×
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
0×0.0×
Arcus Biosciences logo
Arcus BiosciencesRCUS
0.2×+0.1×

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M—
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K—
Free cash flow-$3.7M—

Valuation

See full
Market cap$84.62M+66.4%
Enterprise value$103.7M—

Returns & leverage

See full
Return on equity470%—
Current ratio0.1×-1.1×